Recce Pharmaceuticals Ltd (ASX:RCE)
Australia
· Delayed Price · Currency is AUD 0.440
+0.010 (2.33%)
Mar 10, 2026, 11:10 AM AEST
Recce Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.37 | 10.45 | 4.42 | 1.56 | 11.58 | 20.87 | Upgrade
|
| Short-Term Investments | - | 0.24 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 0.37 | 10.69 | 4.42 | 1.56 | 11.58 | 20.87 | Upgrade
|
| Cash Growth | -81.21% | 142.02% | 182.74% | -86.52% | -44.51% | 678.21% | Upgrade
|
| Other Receivables | - | 0.2 | 0.16 | 0.09 | 0.18 | 0.25 | Upgrade
|
| Receivables | 0.05 | 0.2 | 0.16 | 0.09 | 0.18 | 0.25 | Upgrade
|
| Other Current Assets | 0.26 | 0.5 | 0.56 | 0.3 | 0.42 | 0.06 | Upgrade
|
| Total Current Assets | 0.87 | 11.39 | 5.14 | 1.95 | 12.18 | 21.18 | Upgrade
|
| Property, Plant & Equipment | 1.17 | 1.03 | 1.23 | 0.61 | 0.44 | 0.5 | Upgrade
|
| Other Intangible Assets | - | 0 | 0 | - | 0 | 0 | Upgrade
|
| Total Assets | 2.04 | 12.41 | 6.37 | 2.56 | 12.62 | 21.68 | Upgrade
|
| Accounts Payable | 5.63 | 2.18 | 3.97 | 0.95 | 0.48 | 0.49 | Upgrade
|
| Accrued Expenses | 0.71 | 0.93 | 0.57 | 0.41 | 0.38 | 0.39 | Upgrade
|
| Short-Term Debt | - | - | 9.69 | 3.05 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | 1.53 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.25 | 0.22 | 0.22 | 0.15 | 0.07 | 0.11 | Upgrade
|
| Other Current Liabilities | 4.82 | 1.27 | 0.62 | 0.29 | 1.51 | 0.09 | Upgrade
|
| Total Current Liabilities | 11.42 | 6.13 | 15.07 | 4.85 | 2.45 | 1.08 | Upgrade
|
| Long-Term Debt | - | 8.6 | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.55 | 0.42 | 0.59 | 0.1 | - | 0.01 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.28 | 0.32 | 0.24 | 0.19 | 0.12 | 0.09 | Upgrade
|
| Other Long-Term Liabilities | 8.41 | 0 | -0 | - | 0 | - | Upgrade
|
| Total Liabilities | 20.66 | 15.47 | 15.89 | 5.14 | 2.56 | 1.18 | Upgrade
|
| Common Stock | 81.73 | 81.5 | 54.84 | 44.11 | 43.97 | 43.3 | Upgrade
|
| Retained Earnings | -108.06 | -91.5 | -70.08 | -55.54 | -42.46 | -31.47 | Upgrade
|
| Comprehensive Income & Other | 7.72 | 6.95 | 5.71 | 8.83 | 8.55 | 8.68 | Upgrade
|
| Shareholders' Equity | -18.62 | -3.05 | -9.52 | -2.59 | 10.06 | 20.5 | Upgrade
|
| Total Liabilities & Equity | 2.04 | 12.41 | 6.37 | 2.56 | 12.62 | 21.68 | Upgrade
|
| Total Debt | 0.81 | 10.77 | 10.5 | 3.3 | 0.07 | 0.13 | Upgrade
|
| Net Cash (Debt) | -0.44 | -0.08 | -6.09 | -1.74 | 11.51 | 20.75 | Upgrade
|
| Net Cash Growth | - | - | - | - | -44.53% | 698.25% | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | -0.03 | -0.01 | 0.07 | 0.13 | Upgrade
|
| Filing Date Shares Outstanding | 289.18 | 288.37 | 231.61 | 196.83 | 178.02 | 173.78 | Upgrade
|
| Total Common Shares Outstanding | 289.18 | 288.37 | 203.99 | 178.25 | 177.65 | 173.78 | Upgrade
|
| Working Capital | -10.55 | 5.26 | -9.93 | -2.9 | 9.74 | 20.1 | Upgrade
|
| Book Value Per Share | -0.06 | -0.01 | -0.05 | -0.01 | 0.06 | 0.12 | Upgrade
|
| Tangible Book Value | -18.62 | -3.05 | -9.52 | -2.59 | 10.06 | 20.5 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | -0.01 | -0.05 | -0.01 | 0.06 | 0.12 | Upgrade
|
| Machinery | 0.97 | 0.95 | 0.92 | 0.79 | 0.74 | 0.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.